Chimerix

Chimerix

Chimerix

Developing important antiviral medicines for the treatment of life-threatening diseases. $CMRX
Founded
2002
Raised
$217.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$122,000,000
Post-IPO equity - 2014
$45,000,000
Venture capital (Series F) - 2011
Alta Partners New Leaf Venture Partners Pappas Ventures
Team Size
50+
Employees
Xconomy

Chimerix, TransEnterix, BDSI, Duke Energy & More NC Innovation News

Health
The Motley Fool

Here's Why Chimerix Inc Jumped 14.3% in April

Xconomy

Precision BioSciences, Chimerix, Spreedly, & More NC Innovation News

Health Funding
Xconomy

After Failed Trial, Chimerix Shuts Down Two More Phase 3 Tests

Health
The Motley Fool

Chimerix Inc. Is Roaring Higher Again -- Here's Why --

Stock markets
The Motley Fool

Why Chimerix Inc. Is Up Big Today --

Stock markets Health
Xconomy

Chimerix, DeSimone, Merz, & More in NC Innovation News

Funding Health
The Motley Fool

Why Valeant Pharmaceuticals, Chimerix, and 3D Systems Slumped Today --

Stock markets Health
The Motley Fool

Why Chimerix's Shares Collapsed Today --

Stock markets Health
Xconomy

Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial

Health